Anti-Tumor Effects of |
Medical Hypotheses (1997) 49, pg 297-300
|
Electric Current
Helps Wipe Out Liver Tumours by Nic Rowan Thursday, November 08, 2001 2:06 p.m. EST - - - - - ADELAIDE, Australia (Reuters Health) - Surgeons here who pioneered the use of electrical current to destroy liver tumours say they are optimistic that the treatment could be used for tumours of the pancreas and kidney as well. The treatment, called electrolysis, involves placing electrodes into liver tumours and surrounding tissue. A small electric current is then passed through the electrodes to destroy the tissue. In some cases, affected parts of the liver are removed surgically. The leader of the surgical team investigating the treatment, Professor Guy Maddern of Adelaide University, told Reuters Health that the method causes a change in the acidity of the tissue and "poisons the tumour." "It is less destructive than surgical removal of the tumour, and can be used to treat tumours that are awkwardly located, such as next to large blood vessels," he added. Maddern and his colleagues have treated 10 patients, with follow-up ranging from 6 to 43 months. Nine of the patients had bowel cancer that had spread to the liver, and one had cancer that originated in the liver. In order to be included in the study, patients had to have no other untreatable tumour outside the liver, and to be fit for major surgery. All patients, said Maddern, had extensive disease in the liver. Eight of the patients show no evidence of residual tumour at the treatment site. Five of these eight patients have developed new areas of tumour spread, while three have no evidence of new cancer growth. "In any case, after surgical intervention without electrolysis, 60% of patients would be expected to develop new disease," Maddern said. "We are trying to increase the percent who don't get new disease." When added to surgery to remove a tumour, Maddern noted, electrolysis increased the percentage of patients who were treatable with surgery from 20% to 25%. "We have been developing this technique for 5 years. We are now ready to move forward and are considering tumours of the pancreas and kidney," Maddern told Reuters Health. "They will be the next step." |
Alternative
cancer treatment with few side effects: The Electro Carcinoma
Therapy (ECT) Original article in German: http://www.naturmednet.de/krebs/tumor.ect.html The Electro-Carcinoma Therapy is a form of tumor treatment that is hardly known. So far, some empirical values and a first study are present. The Institute for Natural Health Methods in Marburg Germany uses ECT. The principle: A weak direct current is applied to the tumors, which can shrink, as a direct consequence and even disappear completely. From China came the first results of a larger case study which uses the ECT treatment with over 10,000 patients in the period of 1987 to 2000. One of the central results: in just over 30% of the cases, it brought about the dissolution of the tumors, and in somewhat more than 40%, to the reduction of the tumor. The individual success values hang thereby, among other things on the kind of tumor and size as well as the stage of the illness. The Chinese medical profession apply the energy in particular by means of platinum wire electrodes, in the form of needles, injected directly into the tumors. In contrast; the Marburg Institute works almost exclusively with plate formed metal electrodes applied to the skin. "the use of plates is gentler, possesses a higher acceptance with the patients and is just as effective as the therapy with needles", explains Dr. Bernhard Weber, head of the institute. First intermediate results of the local treatments seem to confirm the results of the Chinese study. The Electro-Carcinoma Therapy is a local, low side-effect procedure that can be treated on an outpatient basis. In the two to three hour treatment, energy flows through the tumor. Some patients need only two or three sessions before the tumour will "melt", others need more. With the help of a special computer monitor program and controls, the physician controls the treatment and observes the procedures in the body and the growth. The medical skill lies in being able to place the electrodes in the correct location and setting of the optimal amperage - this must be different depending upon tumour size, density and type. ECT can and should be used, depending upon illness, together with other forms of treatment. In order to control the formation of secondary growths (metastases) with malicious tumors, Dr. Weber advises to combine the use of ECT with radio and/or chemotherapy. ECT does not replace good conventional therapy possibilities; on the other side ECT can be a new therapeutic chance where conventionally difficult or hardly treatable tumors and secondary growths are present. ECT is suitable for both surface as well as more deeply located tumours, explains the Institute. Secondary growths in bones cannot be treated as effectively with this method. Even if the tumor has already been pre-treated with irradiation or chemotherapy, the Electro Carcinoma Therapy can still be used. Further information: Institut fr Naturheilverfahren & Naturheilkunde-Tagesklinik mit Schmerzambulanz (Institut for natural health method & naturopathy outpatient hospital with pain clinic) Contact: Dr. Bernhard Weber, email: b.weber@firemail.de Uferstr. 1, 35037 Marburg, Germany Tel: +49 6421 68430; FAX: +49 6421 684350 Literature on ECT: Dr. med. Rudolf Pekar: Die perkutane Bio-Elektrotherapie bei Tumouren (The percutaneous bio electrical therapy with tumours). Vienna, Munich, Berlin 1996. Dr. med. Rudolf Pekar/Dr. med. Nikolai N. Korpan: Cancer. Vienna, Munich, Berne 2002. |
Electro Cancer
Treatment (ECT) Source: http://www.klinik-st-georg.de/englisch/ELEKTRO.HTM I. Introduction Electro medicine has been widely used for many years, especially in orthopedics where it has been used for regeneration, i. e., to increase the healing process in broken bones (1) and pain purposes. In Oncology, however, the use of electromedicine (ECT) is relatively new and stems from research investigations of Pekar (2) and Nordenstrm (3). Since 1987, St. George Hospital has treated hundred of patients with this method of treatment. Direct current can be directed into tumorous tissue (skin metastases, lymph node metastases or isolated organ metastases) through the application of electrodes. If the total amount of direct current is high enough, this procedure results in the destruction of cancerous cells and in extreme cases, no necrotization [burning]. II. Physical-chemical principles of ECT As soon as direct current is connected to the electrodes, different electrochemical reactions influence the pH-value and can cause electrolysis of tumor tissue. Depolarization of the cell membranes changes the cellular environment forcing the tumor cells to be gently destroyed. Consequence of this process is the interruption of certain functions within the cancerous cells, which in turn, can lead to the destruction of these cells. Tumor tissue is more susceptible to damage from direct current than normal tissue, thus allowing the destruction of cancerous cells to occur when direct current is applied directly to the malignant tissue. The body 's own catabolic processes remove the destroyed malignant tissue from the body. It is also possible that through this process the immune system starts fighting all other cancer cells within the body. Once ECT or Galvano (as it is commonly known) treatment is successfully completed, the cancerous area heals and is replaced with scar tissue. III. What types of tumor are suitable for ECT? ECT is suitable for all types of superficial or deep seated tumors, which can be reached by needle electrodes. Specifically, however, are: - small breast carcinomas or isolated axiillary, supraclavicular and thoracic nodes. - all tumors of the ENT area, especially after radiation or chemotherapy. - skin carcinomas e. g. Basaliome, Spinoccellllular carcinoma, Melanoma etc. - gynecological carcinomas - soft tissue tumors IV. Special form of ECT using cytostatic substances (Iontophoresis) The destructive effect of the direct current on tumorous tissue can be enhanced by the simultaneous administration of cytostatic substances, for example, Mitomycin, Adrimycin, Epirubicin and Cis-Platinium. Most cytostatic substances are positively charged, which when inserted onto the anode in an electrical field directed through tumorous tissue move to the cathodes (iontophoresis movement). In this way, cytostatics can be introduced into the tumorous tissue in a very targeted and concentrated manner. This method can be more effective on the tumor side than standard systemic chemotherapy or local cytostatic perfusion. Cytostatic substances are best applied to hollow organs, for example, esophagus, bladder, stomach and rectum. The membrane potentials are changed so much by the current that the cells open and absorb cytostatic substances more rapidly. V. How is the treatment carried out? Normally the treatment is carried out under local anaesthetic and on an outpatient basis. The size of the tumor determines how many needle electrodes are required, however, a minimum of 2 are always used. These are introduced into the tumor through the skin. The electrodes should not be further than 1.5cm apart. The minimum required electric field must be 35 coulombs/ml although up to 90 coulombs/ml are normally used. During the treatment, the patient will experience a slight pressure pain or a slight tingling in the treated area. Direct current brings about long lasting pain relief because it inhibits the activity of sensory nerve fibers. Therefore there is no pain after treatment. However because the cancerous tissue is being destroyed through this method of treatment, it is normal that inflammation occurs for a couple of days afterwards. The cancerous tissue is broken down naturally, which when eliminated from the body is replaced by scar tissue. Superinfections rarely occur. ECT replaces operations and radiation treatment. Judging by the very positive therapy results, it can be assumed, that ECT will become an important form of treatment for malignant diseases. Literature - Senn E. Electro therapy, Thieme-Verlag - Pekar R. Percutaneous galvano therapy of tumors, Verlag W.Maudrich, Vienna-Munich-Bern - Nordenstrom BEW The European Journal of Surgery Suppl. 577, Pg 93-109 Scandinavian University Press - Douwes F. R. The basics of electrochemical cancer treatment 1994 - Szasz. A. Advanced alternative medicine AAAAM-Series - Pleasnicar A. Electric treatment of human melanoma skin lesions with low level direct current. The European Journal of Surgery Suppl 574, Pg 45-49. Scandinavian University press. - Yunqin Song Electrochemical treatment in the treatment of malignant tumors on the body surface. The European Journal of Surgery Suppl 574, Pg 41-43. Scandinavian University Press. - Kuanhong Quan Analysis of the clinical effectiveness of 144 cases of soft tissue and superficial malignant tumors treated with electrochemical therapy. The European Journal of Surgery Suppl 574, Pg 37-40. Scandinavian University Press. |
British Journal of
Cancer, #69, 1994, pp 875-878 The effects of low-level direct current therapy on a preclinical mammary carcinoma: tumour regression and systemic biochemical sequelae from www.ncbi.nlm.nih.gov/pmc/articles/PMC1968917/ Direct current therapy (DCT) offers considerable promise as a low-cost, minimally invasive anti-tumour treatment. While the tissue-destructive effects of low, direct electrical currents have been known for many years, development of a clinically acceptable therapy has been slow, hindered, for example, by uncertainties regarding the quantitation of the dose-response relationship. Our previous qualitative study demonstrated that both anodic and cathodic treatments caused prompt and massive tumour necrosis (Dodd et al., 1993). The present work provides an absolute and relative quantitation of the extent of tumour regression/necrosis with charge and polarity. In common with previous workers, we noted that tumour lysis and volume decrease was extremely rapid after DCT. Tumours were treated by DCT 6-10 weeks after inoculation when they were approximately spherical and 6-1Omm in diameter. When volume regression was analysed against various parameters of dose delivered, the best correlation was obtained when plotted against charge [electrical], although it did appear that higher currents resulted in greater volume regression for the same charge passed, possibly because of higher rates of production of electrolyte products [intracellular potassium released into blood during tumor breakdown]. Regression analysis of the data showed a linear relationship between the volume of regression induced in the tumor and the charge passed when the electrode in the tumor was an anode [positive]. [The study graphs showed a 518mm3 reduction in tumor size from treatment with 10 Coulombs. Predictable tumor reduction volume is equal to 50 times the Coulombs of electrical charge, plus 18.] Using this program, maximum decrease in tumour volume and tumour regrowth delay were calculated for each treated tumour, relative to the size- matched control curve. In some cases the decrease in volume was equal to the total initial volume, and in a few cases no regrowth of the tumour was observed, even after several months, i.e. the animals were 'cured' of their tumours. However, in this first series, only those tumours in which partial damage (i.e. less than total volume regression) occurred were used to quantify the effects of treatment. In those tumours in which the relative volume regression was 100%, the absolute volume regression attainable for that dose was unknown. Mechanistically, if the damage to the tumour at each electrode site were primarily due to local pH changes caused by these reactions, one would expect a ratio corresponding to the square root of the expression D(H3O)/D(OH-), where D is the diffusion coefficient. This corresponds approximately to 1.4. Our results indicate a ratio of 50/33 = 1.5, which is close to that predicted. Regression analysis of the experimental data showed a linear relationship, the line of best fit being given by this equation: G=.2D + 1.4 where G is the growth delay in days and D is the maximum percentage volume decrease. [So 21.4 days is needed for a 100% decrease in volume.] Moreover, our comparison of the effects of polarity of the electrode implanted in the tumour demonstrates the greater efficacy of the anode [positive voltage] over the cathode [negative voltage]. |
My email to Dr. Bernhard Weber of NaturMedNet, the
German cancer clinic using ECT against cancer :
"I know that the electro-carcinoma
therapy in China had only a 30% success rate
but the Chinese have low
immunity due to too much toxins (environmental).
What success rate does
your clinic have?
thank you very much
His
response:
Dear sir
The Chinese results, published in a
report with 9011 patients, are very different. If the tumor is very big
the results are not so good, if they are small they are better. They
treated with platinum needles during operation or with local analgesic
injections. We treat 95% with plates on the skin, without analgesics. We
have estimated positive results in 30 to 70% of the patients, but we
combine it with a lot of other therapies.
With friendly regards
Dr.
Weber
Click
Here for more articles about ECT from the same
German clinic.
Important Notes from the above research: Only 3 of 20 of Nordenstromsī patients didnīt have a recurrence of cancer some time after treatment. I believe it is because they didnīt change their habits that affect their immunity. Using electricity or anything else to kill tumors is only a small part of a complete cancer treatment. If you think you can continue to be lazy about your health you are DEAD wrong. If you want to be healthy you have to cross the line and be a health nut like me. ha! Itīs great to be healthy. I couldnīt give a care what people say about my health habits since they are just a step away from getting cancer themselves. Iīm a health nut and proud of it! Maybe it's time for you to start caring about every aspect of your health.
The following paper lists other papers that used human test subjects instead of rodents:
Tumor Treatment By Direct
Electric Current: Computation Of Electric Current And Power Density
Distribution
University of Ljubljana, Faculty of Electrical Engineering,
Slovenia, Institute of Oncology
"It has previously been shown that
electrotherapy (ET) by low-level direct current is an effective,
inexpensive, and minimally invasive tumor treatment modality. Tumor growth
retardation has been demonstrated in different murine [rodent] tumor
models (ref: 3, 5, 10, 11, 12, 14, 21, 23) as well as in patients (ref: 1,
17, 18, 20, 28)."
1)
Radiological Evidence of Response to Electrochemical Treatment of Breast
Cancer, Clinical Radiology 43, 84-87, 1991
17) Biologically Closed Electric Circuits: Activation of Vascular
Interstitial Closed Electric Circuits for Treatment of Inoperable Cancers,
Journal of Bioelectricity 3, 137-153, 1984, B. Nordenstrom
18) Electrochemical Treatment of Cancer. 1: Variable
Response to Anodic and Cathodic Fields, American Journal of Clinical
Oncology 12, 530-536, 1989
20) Electric
Treatment of Human Melanoma Skin Lesions With Low Level Direct Electric
Current: An Assessm
DC Electricity is also powerful in helping heal wounds and ulcers. click here